SCHEMBL27487488

SCHEMBL27487488

CC([SiH3])C(C)(C)OC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13749821 0.74
SCHEMBL3038426 0.74 TDP1 (0.46)
Ammonia Solution, Strong SCHEMBL3682014 0.72 TDP1 (0.43)
SCHEMBL1318404 0.70
SCHEMBL3044962 0.69 TDP1 (0.40)
SCHEMBL2219653 0.67
SCHEMBL3040137 0.67 TDP1 (0.39)
SCHEMBL3391945 0.65
Tert-Butyl Formate SCHEMBL2252376 0.65 TDP1 (0.72)
Tert-Butyl Formate SCHEMBL28884215 0.65 TDP1 (0.72)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103930426-B As [1,2,3] triazols [4, the 5-D] pyrimidine derivatives of Cannabined receptor 2 activators HOFFMAN-LA ROCHE LTD. (CH) 2016-05-11 CN disclosed
CN-1256326-C Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 2006-05-17 CN disclosed
CN-1202152-A Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 1998-12-16 CN disclosed